🌏 Delivering Specialty Medicines to South-East Asia | ☎ +63 952 488 3302 | ✉ [email protected]
MedsMonk
Login / Register
Sign inCreate an Account

Lost your password?

Or login with

Facebook
0 items ₱ 0.00
Menu
MedsMonk
0 items ₱ 0.00
  • Home
  • Medicines
    • Gynecology
    • Hepatitis
    • Men’s Health
    • Oncology
    • Sexual Wellness
    • Women Health
  • Blog
  • Contact Us
  • Specialty Medicines
  • Regional Health
  • Long-Term Care
[elementor-template id="6287"]
coloncancer
29 Jun
Uncategorized

EU Approves New Targeted Treatment Combo for Advanced BRAF-Mutant Colon Cancer

  • June 29, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
The European Commission has given the thumbs up to a new combination treatment for advanced bowel cancer. The therapy will use two targ...

Continue reading

14 May
Cancer Medicine, Diagnosis and Detection

Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.nnThis marks an important milestone in the treatm...

Continue reading

06 May
Breast Cancer

FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve with adva...

Continue reading

Pancreatic Cancer
02 May
Health

How Daraxonrasib Doubled Survival in Pretreated Metastatic Pancreatic Cancer: A Breakthrough Explained

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 2, 2026.nnPancreatic cancer remains one of the most aggres...

Continue reading

brain tumor
14 Apr
Cancer Medicine

FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.nnBrain tumors, especially high-grade gliomas, ...

Continue reading

stages of lung cancer
07 Apr
Cancer Medicine, Lung Cancer, Treatments & Therapies, Understanding Cancer

What are the 4 stages of lung cancer?

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026.nnLung cancer staging is a critical step in unde...

Continue reading

breast cancer
01 Apr
Breast Cancer, Understanding Cancer

First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026.nnMetastatic breast cancer (mBC) remains a major...

Continue reading

lungcancer
25 Mar
Cancer Medicine, Lung Cancer, Understanding Cancer

Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026.nnThe treatment landscape for EGFR-mutated non–...

Continue reading

breast cancer
23 Mar
Breast Cancer, Cancer Medicine, Women Health

Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue t...

Continue reading

breast cancer radiation therapy
20 Mar
Breast Cancer, Treatments & Therapies, Understanding Cancer, Women Health

Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026.nnFor many years, patients who had previously u...

Continue reading

MedsMonk Logo

We are on a mission to ensure that every patient has access to affordable medicines for life-threatening conditions, delivered with compassion right to their doorstep.

Facebook Instagram Twitter Telegram Linkedin Pinterest Tiktok

Company

  • About Us
  • Blog/Resources
  • Contact Us
  • Molecules

Speciality Medicines

  • Oncology
  • Gynecology
  • Hepatitis
  • Sexual Wellness
  • Men’s Health
  • Women Health

Most Search Molecules

  • Tucatinib
  • Osimertinib
  • Ponatinib
  • Ribociclib
  • Eltrombopag

Policy / Legal

  • Terms and Conditions
  • Privacy Policy
  • Grievance Redressal Policy
  • Editorial Policy

Order Policy

  • Order & Payment Policy
  • Cancellation Policy
  • Shipping & Delivery Policy
  • Return & Refund Policy

Country

  • Australia
  • Hong Kong
  • Malaysia
  • Philippines
  • Singapore
  • Thailand

At MedsMonk, we aim to provide you with trustworthy and expert-reviewed information. However, this content is not a substitute for professional medical advice. It's intended for informational purposes only and may not cover every detail about health conditions, lab tests, medications, side effects, interactions, and warnings. Always consult your doctor for any questions about your health or medicines. We want to support your relationship with your healthcare provider, not replace it!

Call Us: +63 952 488 3302

Subscribe

Subscribe via Email →

  • Menu
  • Categories
Set your categories menu in Header builder -> Mobile -> Mobile menu element -> Show/Hide -> Choose menu
  • Home
  • Medicines
    • Gynecology
    • Hepatitis
    • Men’s Health
    • Oncology
    • Sexual Wellness
    • Women Health
  • Blog
  • Contact Us
  • Specialty Medicines
  • Regional Health
  • Long-Term Care
  • Login / Register
Shopping cart
Close
Facebook WhatsApp WhatsApp Telegram
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info More info Accept
DMRC Complaint Portal